Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04269083 | A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction(BoRgES) | unknown | N/A | 128 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 0 | Apr 17, 2020 | clinicaltrials |
| NCT04125849 | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | unknown | N/A | 160 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| 1 |
| Apr 15, 2020 |
| clinicaltrials |
| NCT02279134 | Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma | unknown | Phase 2 / Phase 3 | 360 | Zefen XiaoUNKNOWN | 1 | Apr 3, 2020 | clinicaltrials |
| NCT03635619 | The Application of 3T MRI in Esophageal Cancer | unknown | — | 400 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 1, 2020 | clinicaltrials |
| NCT02123381 | Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 100 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT04194463 | Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study(ChemoFit) | unknown | N/A | 40 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT04269369 | Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients | unknown | Phase 4 | 250 | Jessa HospitalOTHER | 0 | Feb 13, 2020 | clinicaltrials |
| NCT03603756 | SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer | unknown | Phase 2 | 45 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT03094351 | Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy(RAE vs CTE) | unknown | Phase 3 | 360 | Shanghai Chest HospitalOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03913182 | Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer | unknown | Phase 2 | 39 | Shanghai Chest HospitalOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT04229537 | Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC | unknown | Phase 1 | 60 | Sinocelltech Ltd.INDUSTRY | 0 | Jan 18, 2020 | clinicaltrials |
| NCT04229849 | Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 164 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 18, 2020 | clinicaltrials |
| NCT04224363 | Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction | unknown | N/A | 80 | Shandong UniversityOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT04006041 | Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer | unknown | Phase 2 | 44 | Jianhua FuOTHER | 1 | Dec 26, 2019 | clinicaltrials |
| NCT04066335 | Study to Evaluate the Safety of Nanoxel M Inj. | unknown | — | 1,498 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | Dec 18, 2019 | clinicaltrials |
| NCT04162860 | Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy | unknown | N/A | 100 | University of ZurichOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT03985670 | Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer | unknown | Phase 2 | 30 | Henan Cancer HospitalOTHER_GOV | 1 | Dec 12, 2019 | clinicaltrials |
| NCT02520453 | Adjuvant Durvalumab for Esophageal Cancer | unknown | Phase 2 | 86 | Samsung Medical CenterOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT04190121 | Perioperative Nutritional Support in Esophageal Cancer Patients(NEEC) | unknown | N/A | 110 | THEODOROU DIMITRIOSOTHER | 1 | Dec 9, 2019 | clinicaltrials |
| NCT04189393 | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery(MA-PPING) | unknown | — | 60 | Radboud University Medical CenterOTHER | 0 | Dec 6, 2019 | clinicaltrials |
| NCT04177875 | Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer(T+TP) | unknown | Phase 2 | 44 | Tongji HospitalOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT04170257 | Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions | unknown | N/A | 10,000 | Peking University Cancer Hospital & InstituteOTHER | 1 | Nov 20, 2019 | clinicaltrials |
| NCT03021200 | Laser Fluorescence in Cancer Surgical Treatment | unknown | N/A | 270 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT04158414 | Applying PET/MR in Oncology - a Prospective Project | unknown | N/A | 500 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Nov 8, 2019 | clinicaltrials |
| NCT01691664 | Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer | unknown | N/A | 40 | Capital Medical UniversityOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT04137679 | Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO | unknown | Phase 2 | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT03285035 | Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer(Cryotherapy) | unknown | — | 50 | Western Regional Medical CenterOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT04115618 | SIB in Upper Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 65 | Fudan UniversityOTHER | 1 | Oct 4, 2019 | clinicaltrials |
| NCT02072720 | Angiogenic Factor Expression During Fractionated Irradiation | unknown | Early Phase 1 | 40 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT03940001 | A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer | unknown | Early Phase 1 | 20 | Zhejiang Cancer HospitalOTHER | 1 | Sep 9, 2019 | clinicaltrials |
| NCT04074447 | The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer | unknown | — | 80 | Sun Yat-sen UniversityOTHER | 1 | Sep 9, 2019 | clinicaltrials |
| NCT04027088 | Effect of Preoperative Immunonutrition in Upper Digestive Tract | unknown | N/A | 178 | Complexo Hospitalario Universitario de A CoruñaOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT04054518 | Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma(DESC) | unknown | Phase 2 | 22 | Tiago BiachiOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT02292914 | Prospective Analysis of Robot-Assisted Surgery | unknown | N/A | 1,120 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02858206 | Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma | unknown | Phase 2 | 120 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 26, 2019 | clinicaltrials |
| NCT04032353 | Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy | unknown | N/A | 10,000 | Yanqing LiOTHER | 1 | Jul 25, 2019 | clinicaltrials |
| NCT03185988 | Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System | unknown | Phase 2 | 100 | Shen LinOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT03940976 | Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01) | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Jun 11, 2019 | clinicaltrials |
| NCT03927495 | KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 100 | Shanghai Chest HospitalOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT03922230 | Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer | unknown | — | 300 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 19, 2019 | clinicaltrials |
| NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | unknown | Phase 2 | 264 | Sun Yat-sen UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02812641 | Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC | unknown | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03857763 | A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 40 | Hebei Medical University Fourth HospitalOTHER | 0 | Feb 28, 2019 | clinicaltrials |
| NCT02177552 | Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma(SEED) | unknown | Phase 2 | 98 | Rigshospitalet, DenmarkOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03833466 | Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)(ECMTPneo) | unknown | Phase 2 | 15 | Peking UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02353936 | A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 30 | Yonsei UniversityOTHER | 1 | Feb 11, 2019 | clinicaltrials |
| NCT01745107 | Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;(IMRT) | unknown | Phase 3 | 240 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03817567 | Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 1 / Phase 2 | 50 | Sinocelltech Ltd.INDUSTRY | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03817658 | A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC | unknown | Phase 2 | 725 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Apr 17, 2020source: clinicaltrials